OPA-6566

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameOPA-6566
Drug Alias NameOPA-6566
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A2a receptor agonists
TargetsAdenosine A2a receptor
Therapy Area/IndicationsGlaucoma, Open-AngleOcular Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOtsuka Holdings Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOtsuka Pharmaceutical Co LtdKubota Vision Inc
Active IndicationsN/A
Inactive IndicationsGlaucoma, Open-AngleOcular Hypertension

Other Information

ATC CodeN/A
Related LinksN/A